Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04021355 · ClinicalTrials.gov registry record · NA
Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT04021355 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 53 participants.
The verdict
NCT04021355, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
Experimental data have shown that timing of sodium intake impacts diurnal patterns of sodium excretion. The purpose of this study is to test the hypothesis that the time of day for salt intake impacts (1) blood pressure rhythms and urinary sodium excretion and (2) circadian timing of factors responsible for blood pressure regulation and cardiometabolic health in obese individuals. These studies will address two aims. The first aim will test the hypothesis that limiting high salt intake prior to sleep increases day-night differences in blood pressure, improves timing of urinary sodium excretion, and improves metabolic risk factors. The second aim will test the hypothesis that limiting high salt intake prior to sleep preferentially improves rhythmicity in peripheral vs. central circadian clock factors linked to renal sodium handling. The proposed hypothesis-driven studies will determine how timing of sodium intake affects diurnal blood pressure and circadian timing of factors responsible for blood pressure control and metabolic health, with the ultimate goal of identifying novel strategies to treat nocturnal hypertension and metabolic disease in obesity.
Interventions
- OTHER Oral sodium supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2020-07-14 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04021355
The ClinicalTrials.gov registry entry for NCT04021355 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral sodium supplementation is the first listed.
NCT04021355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04021355 about?
NCT04021355 is a clinical study titled "Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans". Experimental data have shown that timing of sodium intake impacts diurnal patterns of sodium excretion. The purpose of this study is to test the hypothesis that the time of day for salt intake impacts (1) blood pressure rhythms and urinary sodium excretion and (2) circadian timing of factors respons...
What is the current status of trial NCT04021355?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2020-07-14. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT04021355?
The interventions under investigation include: Oral sodium supplementation (OTHER).
Who is sponsoring clinical trial NCT04021355?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.